Back to Results
First PageMeta Content
Pharmacology / Rheumatology / Centocor / Infliximab / Schering-Plough / BASDAI / Adalimumab / Medicine / Immunosuppressants / Monoclonal antibodies


Predictive factors of infliximab therapy in early active axial SpA Rheumatology Dept. The Third Affiliated Hospital of Sun Yat-sen University Zhiming Lin
Add to Reading List

Document Date: 2014-04-23 04:49:32

Open Document

File Size: 536,33 KB

Share Result on Facebook

City

New York / /

Company

axial SpA / /

Country

China / /

Facility

Results Axial SpA / The Third Affiliated Hospital of Sun Yat-sen University Zhiming Lin / /

MedicalCondition

anti-tumor necrosis / active inflammation / arthritis / allergies / disease / tuberculosis / /

Organization

Third Affiliated Hospital of Sun Yat-sen University Zhiming Lin / /

Person

Ann Rheum / /

Product

T10 / /

Technology

alpha / MRI / X-Ray / /

SocialTag